Guide: WHO R&D Good Participatory Practice for COVID-19 clinical trials: a toolbox
by Mesh Editorial TeamThis toolbox was developed in 2020 for the World Health Organisation COVID-19 Research Roadmap and provides a synthesis of key action points from the WHO GPP-EP guidelines. This “how to” guide gives an overview, tips and resources and will be updated as new resources are completed and approved.
Project Report: “Nothing about us without us”: How families affected by Zika are claiming back control
by Mesh Editorial Team, Natalie HunterThis article introduces a series of videos exploring experiences of the Zika epidemic from different perspectives. Within the videos we hear from mothers of children born with microcephaly and from researchers in Brazil and the UK.
Project Report: Going Viral: The Mother of all pandemics Podcast
by Mesh Editorial Team, Dr Mark Honigsbaum & Hannah MawdsleyLiterature: The Legacy of Zika in Brazil: Women, Needs and Rights
by Debora Diniz, Mesh Editorial TeamEvent: Showcase 2019 - International Society of Neglected Tropical Diseases Festival
by Mesh Editorial TeamRepository: Ebola Response Anthropology Platform
by Mesh Editorial TeamVideo: Association of Public Health Laboratories: Fighting Emerging Infectious Diseases
by Mesh Editorial TeamEvent: The International Society for Neglected Tropical Diseases Festival
by Mesh Editorial TeamLiterature: From ‘Trial Community’ to ‘Experimental Publics’: How Clinical Research Shapes Public Participation
by C. Montgomery & R. Pool, Mesh Editorial TeamThis article argues for a conceptual shift away from the static, singular term ‘trial community’ towards ‘experimental publics’. The authors observe that the term ‘community’ is often employed uncritically and assumes that ‘communities’ pre-exist research; that they are timeless and undifferentiated wholes. ‘Experimental publics’, by contrast, are dynamic, multiple, and impermanent in nature.